- Home
- DARE vs NVNI Comparison
DARE vs NVNI Comparison
Compare DARE & NVNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DARE
- NVNI
- Stock Information
- Founded
- DARE 2015
- NVNI 2019
- Country
- DARE United States
- NVNI Brazil
- Employees
- DARE N/A
- NVNI N/A
- Industry
- DARE Biotechnology: Pharmaceutical Preparations
- NVNI
- Sector
- DARE Health Care
- NVNI
- Exchange
- DARE Nasdaq
- NVNI Nasdaq
- Market Cap
- DARE 26.3M
- NVNI 31.5M
- IPO Year
- DARE N/A
- NVNI N/A
- Fundamental
- Price
- DARE $2.56
- NVNI $0.34
- Analyst Decision
- DARE Strong Buy
- NVNI
- Analyst Count
- DARE 3
- NVNI 0
- Target Price
- DARE $12.50
- NVNI N/A
- AVG Volume (30 Days)
- DARE 39.4K
- NVNI 1.3M
- Earning Date
- DARE 08-11-2025
- NVNI 08-07-2025
- Dividend Yield
- DARE N/A
- NVNI N/A
- EPS Growth
- DARE N/A
- NVNI N/A
- EPS
- DARE N/A
- NVNI N/A
- Revenue
- DARE $25,909.00
- NVNI $31,250,627.00
- Revenue This Year
- DARE $99,756.91
- NVNI $12.05
- Revenue Next Year
- DARE $119.77
- NVNI $15.02
- P/E Ratio
- DARE N/A
- NVNI N/A
- Revenue Growth
- DARE N/A
- NVNI 1491.58
- 52 Week Low
- DARE $2.35
- NVNI $0.14
- 52 Week High
- DARE $4.60
- NVNI $12.19
- Technical
- Relative Strength Index (RSI)
- DARE 33.01
- NVNI 52.81
- Support Level
- DARE $2.37
- NVNI $0.28
- Resistance Level
- DARE $2.54
- NVNI $0.38
- Average True Range (ATR)
- DARE 0.11
- NVNI 0.03
- MACD
- DARE -0.02
- NVNI 0.01
- Stochastic Oscillator
- DARE 11.62
- NVNI 71.58
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
About NVNI Nvni Group Limited
Nvni Group Ltd is a holding company that conducts all of its business through Nuvini SA and Nuvini acquired companies. Nuvini S.A. acquires and operates software companies within SaaS markets in Brazil. Nuvini S.A. is the private serial software business acquirer in Brazil and intends to use funding and capital markets access to continue expanding its acquisition plans in Brazil and Latin America. The Company has determined that it has a single operating and reportable segment which is multi-vertical SaaS solution model.